Findings related to assessing value for private US health plans

American Journal of Pharmacy Benefits

Volumn 2, Issue 3, 2010, Pages 219-228

  Bresnahan, Brian W ^a   Neumann, Peter J ^b   Carlson, Rick ^c   Garrison Jr , Louis P ^c   Sullivan, Sean D ^c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CERTIFICATION; CLINICAL EFFECTIVENESS; CONSUMER ATTITUDE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DRUG EFFICACY; DRUG INFORMATION; DRUG MANUFACTURE; DRUG SAFETY; HEALTH CARE POLICY; HEALTH INSURANCE; HUMAN; INTERVIEW; NEEDS ASSESSMENT; PRACTICE GUIDELINE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REIMBURSEMENT; UNITED STATES;

EID: 77954745748     PISSN: 19454481     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Neumann PJ, Lin P-J, Greenberg D, et al. Do drug formulary policies refl ect evidence of value? Am J Manag Care. 2006;12(1):30-36.
2. AIS Health. Top 25 US health plans, ranked by total enrollment (as of December 2008). http://www.aishealth.com/MarketData/MCEnrollment/MCEnrol_mc01.html. Accessed January 22, 2010.
3. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. 3rd ed. Oxford, United Kingdom: Oxford University Press; 2005.
4. Gold MR, Siegel JE, Russell LB, Weinstein, MC. Cost-Effectiveness in Health and Medicine. Oxford, United Kingdom: Oxford University Press; 1996.
5. Ramsey SD, Veenstra DL, Garrison LP Jr, et al. Toward evidence-based assessment for coverage and reimbursement of laboratory-based diagnostic and genetic tests. Am J Manag Care. 2006;12(4):197-202.
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497.
7. Grundy SM, Cleeman JI, Merz CNB, et al; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines [published correction appears in Circulation. 2004;110(6):763]. Circulation. 2004;110(2):227-239.
8. Fendrick AM, Chernew ME. Value-based insurance design: maintaining a focus on health in an era of cost containment. Am J Manag Care. 2009;15(6):338-343.
9. Golden Rule Insurance Company. Over 10 million Americans now in CDH accounts as more companies go over the 100,000 mark. March 6, 2007. http://www.goldenrule.com/newsroom/gr_cdh_accounts.htm. Accessed June 3, 2008.
10. International Society for Pharmacoeconomics and Outcomes Research and PhRMA Health Outcomes Committee. Health care comparative effectiveness in the United States symposium, prior to the ISPOR 12th Annual International Meeting. May 20, 2007; Arlington, VA.